Q2 2020 · —
Revenue—
Net Income-$2.04M-$2.04M no prior Q2 2019 on file
EPS Diluted-$4.86-$4.86 no prior Q2 2019 on file
Operating Income-$2,035,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2019 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR